Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03931070 · ClinicalTrials.gov registry record · Phase 4
The Effect of Ramelteon on Delirium and Sleep in Patients Admitted to the ICU
A Phase 4 study, sponsored by Rhode Island Hospital.
- Completed
- Registry status
- Phase 4
- Development phase
- 112
- Enrollment target
NCT03931070 is a Phase 4 study that has completed, run by Rhode Island Hospital. The registered enrollment target is 112 participants.
The verdict
NCT03931070, a Phase 4 study, has completed, sponsored by Rhode Island Hospital.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 112 participants
- Enrollment target
Study Summary
Delirium is a disturbance in attention and awareness that occurs over a short period of time. Delirium is common in critically ill patients, and poor sleep quality in the intensive care unit (ICU) often worsens delirium. We aim to lower delirium in the intensive care unit (ICU) by using ramelteon, which is a drug used to improve sleep at night.
Interventions
- DRUG Placebo - Cap
- DRUG Ramelteon
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 112 participants |
| Start Date | 2019-05-09 |
| Est. Completion | 2022-02-01 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03931070
The ClinicalTrials.gov registry entry for NCT03931070 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 112 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Rhode Island Hospital, which has 130 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo - Cap is the first listed.
NCT03931070 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03931070 about?
NCT03931070 is a clinical study titled "The Effect of Ramelteon on Delirium and Sleep in Patients Admitted to the ICU". Delirium is a disturbance in attention and awareness that occurs over a short period of time. Delirium is common in critically ill patients, and poor sleep quality in the intensive care unit (ICU) often worsens delirium. We aim to lower delirium in the intensive care unit (ICU) by using ramelteon, w...
What is the current status of trial NCT03931070?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 112 participants. The study started on 2019-05-09. Estimated completion is 2022-02-01.
What interventions are being tested in trial NCT03931070?
The interventions under investigation include: Placebo - Cap (DRUG), Ramelteon (DRUG).
Who is sponsoring clinical trial NCT03931070?
This trial is sponsored by Rhode Island Hospital, which has 130 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.